
That breakdown of the heart's exquisitely coordinated electrical activity is the essence of ventricular fibrillation, which causes more than 350,000 deaths a year in the United States alone. Factions of cardiac cells quietly riot against the normal rhythmic motions of the heart, disrupting the pumping process and impeding the flow of blood to vital organs.
Since the early 1980s, the implantable defibrillator has helped manage these unpredictable events in patients with heart disease. Surgically tucked beneath the skin and connected to the heart by electrodes, the battery-powered device continually monitors cardiac performance. If it detects the helter-skelter -- and lethal -- activity of ventricular fibrillation, it restores calm by delivering an electric shock.
Life-saving benefits, however, come at a price, and research has focused on building more efficient, less energy-hogging implants. "We don't have any detailed knowledge of what cardiac cells are doing in a physiological sense during defibrillation," says Nitish V. Thakor, professor of biomedical engineering at The Johns Hopkins University, who is modeling the heart's electrical processes at Pittsburgh Supercomputing Center. "Computer modeling provides the scientific rigor necessary for such an understanding, without having to do a zillion experiments."
From the patient's perspective, adds Matthew G. Fishler, "There are psychological, physiological and practical reasons to reduce the energy levels as much as possible." Repeated defibrillations at increasingly higher voltages are painful, can damage heart and surrounding skeletal tissue and hasten battery replacement, an expensive, invasive surgical procedure that takes a further toll on patients.
Wave of the Future
In 1983 animal experiments, researchers replaced the monophasic wave, the wave of choice for implantable defibrillators, with a biphasic wave. By switching electrode polarity, reversing voltage direction, midway through the shock, the biphasic wave significantly reduced the energy and the number of shocks needed to defibrillate, and most implants now incorporate biphasic technology. Yet no one is sure why the biphasic waveform works better. Thakor and Fishler's work offers a compelling answer to the question.
Under Thakor's direction, Fishler designed a computational model of what happens when either mono- or biphasic waves interact with fibrillating heart tissue. This model is the first of its kind to incorporate the gap junctions by which electrical charges travel from cell to cell, thereby simulating cardiac activity both inside and outside cells. "I can't simulate the whole heart," says Fishler, "so I've isolated a fundamental unit of fibrillation, a two-dimensional spiral rotor, sort of like a pinwheel." Rapidly moving and short lived, these roaming, marauding packs of excitation are believed the source of fibrillation.
Modeling these rotors, says Fishler, is computationally demanding. Generating the rotor itself, which represents 350 milliseconds in real time, required more than 100 hours of C90 processing. With the C90, Fishler overcame several problems he encountered with a Connection Machine CM-2. The C90's global memory allowed a significant performance gain in look-up table routines and the algorithms required to simulate defibrillation shocks are better suited to its vector architecture.
The Right Shock
Defibrillation depends on jolting the majority of heart cells, including fibrillating cells, into a fleeting state of simultaneous excitation. Once the cells collectively return to rest, the sinoatrial node, the heart's pacemaker, resumes its role of rhythm king.
A defibrillation current is weakest in regions furthest from the two implant electrodes. Earlier research showed that a monophasic shock lacked the oomph to excite distant cells and, ironically, could induce further fibrillations, while a biphasic shock had no such shortcomings. To account for this difference, Fishler focused on the distant cells, and the model yielded a new insight.
This understanding of the interaction between low-voltage shocks and cardiac cells will aid future research. Just as pacemakers and defibrillators manage heart disease, says Thakor, implants incorporating novel waveforms could help the body's most important muscle do its job more efficiently: "The electrical and mechanical aspects of the heart are linked -- good electrical function leads to better mechanical output. If the heart gets damaged from failure, it may be possible to use electrical stimulation to improve mechanical function."